| 767468 |
FRONTIERS IN ONCOLOGY |
Geometric and Dosimetric Evaluation of Deep Learning-Based Automatic Delineation on CBCT-Synthesized CT and Planning CT for Breast Cancer Adaptive Radiotherapy: A Multi-Institutional Study |
2021-11-09 |
10.3389/fonc.2021.725507 |
Dai Zhenhui, Zhang Yiwen, Zhu Lin, Tan Junwen, Yang Geng, Zhang Bailin, Cai Chunya, Jin Huaizhi, Meng Haoyu, Tan Xiang, Jian Wanwei, Yang Wei, Wang Xuetao |
| 767467 |
FRONTIERS IN ONCOLOGY |
Combined Use of cyclinD1 and Ki67 for Prognosis of Luminal-Like Breast Cancer Patients |
2021-11-09 |
10.3389/fonc.2021.737794 |
Hao Junmei, Zhang Wenfeng, Lyu Yan, Zou Jiarui, Zhang Yunyun, Lyu Jiahong, Zhang Jianbo, Xie Shuishan, Zhang Cuiping, Zhang Jiandi, Tang Fangrong |
| 767466 |
FRONTIERS IN ONCOLOGY |
Antitumor Effects of Evodiamine in Mice Model Experiments: A Systematic Review and Meta-Analysis |
2021-11-09 |
10.3389/fonc.2021.774201 |
Yin Cong, Cheng Jing, Peng Hongbing, Yuan Shijun, Chen Keli, Li Juan |
| 767465 |
FRONTIERS IN ONCOLOGY |
Prognostic Influence of Residual Tumor-Infiltrating Lymphocyte Subtype After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer |
2021-11-09 |
10.3389/fonc.2021.636716 |
da Silva Jesse Lopes, de Albuquerque Lucas Zanetti, Rodrigues Fabiana Resende, de Mesquita Guilherme Gomes, Fernandes Priscila Valverde, Thuler Luiz Claudio Santos, de Melo Andreia Cristina |
| 767464 |
FRONTIERS IN ONCOLOGY |
Chinese Expert Consensus on Iodine125 Seed Implantation for Recurrent Cervical Cancer in 2021 |
2021-11-09 |
10.3389/fonc.2021.700710 |
Jiang Ping, Zou Lijuan, Wei Lichun, Cheng Guanghui, Sun Baosheng, Zhang Fuquan, Wang Ruoyu, Wang Tiejun, Qu Ang, Yuan Xiangkun, Qiu Bin, Wei Shuhua, Liu Zi, Zhang Yunyan, Wang Junjie |
| 767463 |
FRONTIERS IN ONCOLOGY |
Vitamin K2 Inhibits Hepatocellular Carcinoma Cell Proliferation by Binding to 17β-Hydroxysteroid Dehydrogenase 4 |
2021-11-09 |
10.3389/fonc.2021.757603 |
Lu Xin, Ma Panpan, Kong Lingyu, Wang Xi, Wang Yaqi, Jiang Lingling |
| 767462 |
FRONTIERS IN ONCOLOGY |
AMPD1 Is Associated With the Immune Response and Serves as a Prognostic Marker in HER2-Positive Breast Cancer |
2021-11-09 |
10.3389/fonc.2021.749135 |
Wang Long, Zhang Xue, Wang Mengxue, Li Yunhai, Xu Jiali, Wei Jiaying, Li Hongzhong, Ren Guosheng, Yin Xuedong |
| 767461 |
FRONTIERS IN ONCOLOGY |
Cost-Effectiveness of Ipilimumab Plus Anti-PD-1 Therapy Versus Ipilimumab Alone in Patients With Metastatic Melanoma Resistant to Anti-PD-(L)1 Monotherapy |
2021-11-09 |
10.3389/fonc.2021.743765 |
Peng Ye, Zeng Xiaohui, Peng Liubao, Liu Qiao, Yi Lidan, Luo Xia, Li Sini, Wang Liting, Qin Shuxia, Wan Xiaomin, Tan Chongqing |
| 767460 |
FRONTIERS IN ONCOLOGY |
Corrigendum: CDT1 is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma |
2021-11-09 |
10.3389/fonc.2021.801970 |
Cai Chenhui, Zhang Ying, Hu Xu, Hu Wenhui, Yang Sizhen, Qiu Hao, Chu Tongwei |
| 767459 |
FRONTIERS IN ONCOLOGY |
The Value of 18F-FDG PET/CT and Abdominal PET/MRI as a One-Stop Protocol in Patients With Potentially Resectable Colorectal Liver Metastases |
2021-11-09 |
10.3389/fonc.2021.714948 |
Zhou Nina, Guo Xiaoyi, Sun Hongwei, Yu Boqi, Zhu Hua, Li Nan, Yang Zhi |
